We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Results of PROMIS Prostate Cancer Trial Announced

By HospiMedica International staff writers
Posted on 31 Jan 2017
The results of the long-awaited Prostate MRI Imaging Study (PROMIS) trial have been released and are expected to lead to dramatic changes in the way suspected prostate cancer is investigated.

The goal of the trial was to find out whether performing a Multi-Parametric MRI (MP-MRI) scan of the prostate gland before prostate biopsy could safely exclude significant prostate cancer, and prevent the need for an unnecessary biopsy procedure. More...
The researchers recruited 561 men from 11 hospitals. The men underwent MP-MRI scans, template prostate mapping biopsies, and TRUS biopsies. The results of the PROMIS trial were welcomed by the UK Royal College of Radiologists.

The results of the study showed that MP-MRI is nearly twice as sensitive as Transrectal Ultrasound (TRUS) guided biopsies at detecting cancer. MP-MRI had a negative predictive value of 89%, and could form part of a triage helping clinicians decide which patients need a TRUS biopsy reducing the number of biopsies by 25%. MP-MRI would also nearly double the number of correct diagnoses of significant cancers, and reduce false positive diagnoses by around 33%. The inclusion of diagnosis using MP-MRI before biopsy would require more specialized radiologists, and more scanners, but would improve prostate cancer diagnosis significantly, and prevent unnecessary biopsies.


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.